Herein, our team analyzed the clinical feature of glioma patients with ABCC3 expression, finding that differentially expressed ABCC3 was remarkably related to PRS types, histological status, gradations, ages, chemotherapy states, IDH variant, and 1p19q codeletion. Here, IDH1 is linked to glioma.